Main description:

Despite major advances in the understanding of stroke mechanisms that have occurred over the past quarter century, stroke continues to rank among the leading causes of death and disability worldwide. Although currently it may be difficult to believe, early doubts were expressed as to whether inter ventions in risk factors for either coronary disease or stroke would actually lead to a reduction in the incidence of these disorders. However, large clini cal trials in hypertension, carotid disease, atrial fibrillation, and antithrombotic and antiplatelet therapies have effectively demonstrated the efficacy of these targeted interventions in reducing stroke incidence. More recently, after earlier uncertainty regarding the role of elevated lipids as a risk factor for stroke, clinical trials of the statins have also demonstrated a significant reduction in the incidence of ischemic stroke. However, as em phasized in Handbook of Stroke Prevention in Clinical Practice, despite these gains and the initial decline in stroke incidence that did occur in the 1960s and 1970s, the incidence of stroke disappointingly has failed to show a fur ther significant decline since that time. The editors of Handbook of Stroke Prevention in Clinical Practice raise the very important question of whether recognized strategies for stroke preven tion have been widely or effectively implemented. They correctly empha size the critical importance of identifying the mechanism of stroke in each patient so as to properly direct prevention and treatment. As Dr.

Contents:

Epidemiology of Stroke
Eric E. Smith and Walter J. Koroshetz

Subtypes of Ischemic Stroke
John Sims and Walter J. Koroshetz

Hypertension As a Risk Factor for Stroke: Epidemiology of Blood Pressure Risks and Evidence for Treatment Benefit
Donald M. Lloyd-Jones and Christopher J. O'Donnell

Evaluation and Management of Hyperlipidemia for Stroke Prevention
Mehmet Akif Topcuoglu, Ferdinando S. Buonanno, and Peter J. Kelly

Diabetes
Maria Wormack and Ferdinando S. Buonanno

Tobacco and Alcohol
Mehmet Akif Topcuoglu and Karen L. Furie

Diet, Obesity, and Physical Activity
Karen L. Furie. Stroke Prevention With Antiplatelet Therapy, Dominick J. H. McCabe, Peter J. Kelly, and J. Philip Kistler

Hormonal Therapy
MingMing Ning, Karen L. Furie, Jan L. Shifren, and J. Philip Kistler

Stroke Due to Large Artery Atherosclerosis
Karen L. Furie, Stelios M. Smirnakis, Walter J. Koroshetz, and J. Philip Kistler

Craniocervical Endovascular Stenting and Angioplasty
Cenk Ayata and Guy Rordorf

Cardiac Embolism
Karen L. Furie, Aneesh B. Singhal, and J. Philip Kistler

Cryptogenic Emboli and Other Elusive Causes of Stroke
Stelios M. Smirnakis and Walter J. Koroshetz

Less Common Causes of Ischemic Stroke
Raul G. Nogueira and Aneesh B. Singhal

Perioperative Stroke Risk Assessment and Management
David M. Greer and Ferdinando S. Buonanno

Serum Biomarkers in Prediction of Stroke Risk and Outcome
Rachel Farrell and Peter J. Kelly

Genetic Susceptibility and Early Stratification of Stroke Risk
Peter J. Kelly and Karen L. Furie

Index